ArticleJournal of translational medicine2021

N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis.

Fei Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.